News TopFit Impact Programme

11 June 2018

Under the name TopFit Impact Programme, Radboudumc, Radboud University, the University of Twente and Wageningen University & Research, join together in an impact programme aimed at preventing and reducing disease and the burden of disease.


Much progress has been made in recent years in understanding disease processes and the development of new treatment methods. At the same time, the realization that many diseases will remain incurable for the foreseeable future grows. Through smart integration of innovative technologies and knowledge about nutrition and health we can be one step ahead of disease and its burdens.

These integral solutions mean that there will be an ever more personal approach in healthcare. The payoff is a maximum increase in the quality of life of patients and the best perspective on affordable healthcare in an aging society. The goal of the TopFit programme is to contribute to controlling and limiting the cost of healthcare in the future, without making concessions to the quality of life of patients.


TopFit aspires to be a leading health impact programme on three levels: society & health, innovation & (regional) economy and science & technology. Therefore, the researchers work together with key partners in the east of the Netherlands.

During the summer of 2018 the programme will be further specified. After that, more information about TopFit will be available.


Are you interested in the TopFit Impact Programme? Do you want to be involved or do you have questions? Please contact Nathalie Bovy-vanderLugt.

Related news items

Connecting splicing and epigenetics in skin stem-cells

20 November 2018

Sabine Tanis and Klaas Mulder, theme Cancer develoment and immune defense, found that part of this robustness is conferred by functional connections between transcriptional/epigenetic and splicing regulation of genes involved in cell-cell contacts. Their findings are published in Cell reports.

read more

A new autosomal-recessive hypotrichosis syndrome

20 November 2018

Ellen van den Bogaard, theme Inflammatory diseases and Patrick Zeeuwen, theme Infectious diseases and global health, report the first family with cystatin M/E deficiency in Genetics in Medicine.

read more

Cancer cell moves like a predator Lévy walk may be the weak spot of cancer cells

19 November 2018

In contrast to their non-metastatic counterparts, metastatic cancer cells show movement patterns that are also often employed by predators searching for prey. This was shown by an international study on movement patterns of cancer cells published in Nature Communications

read more

Wout Feitz new coordinator EU ERN eUROGEN

19 November 2018

For patients with a rare or complex urogenital disease or condition, eUROGEN is the European Reference Network.

read more

VSB Scholarships for studying or doing research abroad

16 November 2018

For those of you who have supervised or will supervise students who finish their BSc or MSc between 1-3-2018 and 31-12-2019.

read more

Sepsis-associated acute kidney injury: A randomized clinical trial

15 November 2018

Peter Pickkers, theme Infectious diseases and global health, published in JAMA, that among patients who were critically ill with sepsis-associated acute kidney injury, human recombinant alkaline phosphatase compared with placebo did not significantly improve short-term kidney function.

read more
  • Go to